Signaling pathways
-
BA8983 PRN694Summary: PRN694 is an irreversible, highly potent and selective, potent covalently bound dual inhibitor of interleukin 2-inducible cell kinase, resting lymphocyte kinase. -
BA8985 GNE-9822Summary: GNE-9822 is an orally effective and selective inhibitor.
-
BA8986 GSK-2250665ASummary: GSK-2250665A is a selective inhibitor.
-
BA8987 VorolanibSummary: Vorolanib (CM082) is an orally active, potent inhibitor.
-
BA8988 TrapidilSummary: Trapidil is a vasodilator. -
BA8990 AnsornitinibSummary: Ansornitinib is an orally active dual kinase inhibitor that inhibits platelet-derived growth factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR2).
-
BA8991 NVP-ACC789Summary: An inhibitor.
-
BA8992 CT52923Summary: CT52923 is a selective platelet-derived growth factor receptor antagonist with oral activity.
-
BA8993 BMS-605541Summary: BMS-605541 is a selective and orally effective kinase inhibitor.
-
BA8994 PF-4618433Summary: PF-4618433 is a potent and selective inhibitor.